<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8">
        <link rel="stylesheet" href="style.css">
        <title> Omnibuster Section </title>
    </head>

    <body>
        <div class="section">
            <h1> Section s3852 </h1>
            <p> <section id="d3355e27858" identifier="/us/bill/116/hr/748/dA/tIII/stF/ptI/s3852" style="-uslm-lc:I650144"><num value="3852">SEC. 3852. </num><heading>MISBRANDING.</heading><content class="indent0 fontsize10" style="-uslm-lc:I650120">  Section 502 of the Federal Food, Drug, and Cosmetic Act (<a href="https://www.law.cornell.edu/uscode/text/21/352"><ref href="/us/usc/t21/s352">21 U.S.C. 352</ref></a>) <amendingAction type="amend">is amended</amendingAction> by <amendingAction type="add">adding</amendingAction> at the end the following:<quotedContent><subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="ee">“(ee) </num><content>If it is a nonprescription drug that is subject to section 505G, is not the subject of an application approved under section 505, and does not comply with the requirements under section 505G.</content>
</subsection>
<subsection class="indent0 fontsize10" style="-uslm-lc:I650120"><num style="-uslm-lc:emspace2" value="ff">“(ff) </num><content>If it is a drug and it was manufactured, prepared, propagated, compounded, or processed in a facility for which fees have not been paid as required by section 744M.”</content>
</subsection>
</quotedContent>.</content>
</section></p>
        </div>  
    </body>